Ignite Creation Date:
2025-12-24 @ 4:19 PM
Ignite Modification Date:
2026-03-03 @ 12:44 AM
Study NCT ID:
NCT02885766
Status:
UNKNOWN
Last Update Posted:
2020-02-17
First Post:
2016-08-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy of PF-114 for Oral Administration in Adults With Ph+ Chronic Myeloid Leukemia, Which is Resistant to the 2-nd Generation Bcr-Abl Inhibitors or Has T315I Mutation in the BCR-ABL Gene
Sponsor:
Fusion Pharma LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PF-114-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None